Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 5
1967 1
1968 7
1969 6
1970 3
1971 3
1972 8
1973 9
1974 10
1975 9
1976 8
1977 10
1978 12
1979 14
1980 10
1981 14
1982 9
1983 15
1984 19
1985 12
1986 11
1987 11
1988 13
1989 30
1990 19
1991 21
1992 11
1993 20
1994 25
1995 21
1996 27
1997 31
1998 31
1999 37
2000 38
2001 30
2002 38
2003 40
2004 30
2005 39
2006 33
2007 29
2008 39
2009 36
2010 38
2011 37
2012 53
2013 49
2014 47
2015 45
2016 31
2017 51
2018 62
2019 58
2020 39
2021 50
2022 41
2023 27
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

1,372 results

Results by year

Filters applied: . Clear all
Page 1
Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management.
Stockklausner C, Duffert CM, Cario H, Knöfler R, Streif W, Kulozik AE; THROMKID-Plus Studiengruppe der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) and of Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH). Stockklausner C, et al. Ann Hematol. 2021 Jul;100(7):1647-1665. doi: 10.1007/s00277-021-04485-0. Epub 2021 Mar 12. Ann Hematol. 2021. PMID: 33712866 Free PMC article. Review.
However, data on childhood thrombocytosis are rare, and no consensus guidelines for pediatric thrombocytosis exist. ...Here we summarize literature on classification, diagnostics, and clinical management of childhood thrombocytosis....
However, data on childhood thrombocytosis are rare, and no consensus guidelines for pediatric thrombocytosis exist. ...Here we …
A Review and Assessment of Drug-Induced Thrombocytosis.
Vo QT, Thompson DF. Vo QT, et al. Ann Pharmacother. 2019 May;53(5):523-536. doi: 10.1177/1060028018819450. Epub 2018 Dec 10. Ann Pharmacother. 2019. PMID: 30525921 Review.
MEDLINE/PubMed (1966 to September 2018) was searched using the MeSH terms thrombocytosis/chemically-induced and thrombocytosis/etiology. EMBASE (1980 to September 2018) was searched using the EMTAGS thrombocytosis/side effect. ...DATA SYNTHESIS: Drug-induced …
MEDLINE/PubMed (1966 to September 2018) was searched using the MeSH terms thrombocytosis/chemically-induced and thrombocytosis …
Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
Tefferi A, Barbui T. Tefferi A, et al. Am J Hematol. 2019 Jan;94(1):133-143. doi: 10.1002/ajh.25303. Epub 2018 Nov 9. Am J Hematol. 2019. PMID: 30281843 Free article.
Disease Overview: Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms respectively characterized by erythrocytosis and thrombocytosis; other disease features include leukocytosis, splenomegaly, thrombosis, bleeding, microcirculatory s …
Disease Overview: Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms respectively characterized by e …
JAK-mutant myeloproliferative neoplasms.
Levine RL. Levine RL. Curr Top Microbiol Immunol. 2012;355:119-33. doi: 10.1007/82_2011_170. Curr Top Microbiol Immunol. 2012. PMID: 21823028 Review.
Although the Janus family of kinases (JAK1, JAK2, JAK3, and TYK2) has been extensively characterized and investigated, the role of Janus kinase activation in the pathogenesis and therapy of human malignancies was not fully appreciated until recently when multiple studies identifi …
Although the Janus family of kinases (JAK1, JAK2, JAK3, and TYK2) has been extensively characterized and investigated, the role of Janus kin …
Drug-induced thrombocytosis.
Frye JL, Thompson DF. Frye JL, et al. J Clin Pharm Ther. 1993 Feb;18(1):45-8. doi: 10.1111/j.1365-2710.1993.tb00565.x. J Clin Pharm Ther. 1993. PMID: 8473359 Review.
Thrombocytosis is generally defined as platelet counts greater than 400,000/mm3. ...Iron, predictably, can cause a transient thrombocytosis. The beta-lactam antibiotic data are very difficult to interpret due to the possibility of an acute-phase reaction in an infec …
Thrombocytosis is generally defined as platelet counts greater than 400,000/mm3. ...Iron, predictably, can cause a transient throm …
Thrombocytosis and thrombocythemia.
Schafer AI. Schafer AI. Blood Rev. 2001 Dec;15(4):159-66. doi: 10.1054/blre.2001.0162. Blood Rev. 2001. PMID: 11792116 Review.
Thrombocytosis is caused by three major pathophysiological mechanisms: (1) reactive or secondary thrombocytosis; (2) familial thrombocytosis; and (3) clonal thrombocytosis, including essential thrombocythemia and related myeloproliferative disorders. . …
Thrombocytosis is caused by three major pathophysiological mechanisms: (1) reactive or secondary thrombocytosis; (2) familial …
Heavy metal.
Dewarrat N, Blum S. Dewarrat N, et al. Blood. 2020 Oct 22;136(17):1993. doi: 10.1182/blood.2020007779. Blood. 2020. PMID: 33091139 Free article. No abstract available.
Anagrelide: 20 years later.
Emadi A, Spivak JL. Emadi A, et al. Expert Rev Anticancer Ther. 2009 Jan;9(1):37-50. doi: 10.1586/14737140.9.1.37. Expert Rev Anticancer Ther. 2009. PMID: 19105705 Review.
Thrombocytosis is a common feature of chronic myeloproliferative disorders (MPD) and may be asymptomatic or associated with transient microvascular vaso-occlusive symptoms or large vessel arterial or venous thrombosis. ...In this article, we review anagrelide pharmacology, …
Thrombocytosis is a common feature of chronic myeloproliferative disorders (MPD) and may be asymptomatic or associated with transient …
Examination of the relationship between antimicrobials and thrombocytosis.
Forehand CC, Cribb J, May JR. Forehand CC, et al. Ann Pharmacother. 2012 Oct;46(10):1425-9. doi: 10.1345/aph.1R080. Epub 2012 Oct 2. Ann Pharmacother. 2012. PMID: 23032648 Review.
OBJECTIVE: To evaluate whether there is a relationship between antimicrobial therapy and the development of thrombocytosis. DATA SOURCES: Literature was accessed through EMBASE (1977-June 2012) and MEDLINE (1977-June 2012) using the terms thrombocytosis and antimicr …
OBJECTIVE: To evaluate whether there is a relationship between antimicrobial therapy and the development of thrombocytosis. DATA SOUR …
Paraneoplastic thrombocytosis: the secrets of tumor self-promotion.
Lin RJ, Afshar-Kharghan V, Schafer AI. Lin RJ, et al. Blood. 2014 Jul 10;124(2):184-7. doi: 10.1182/blood-2014-03-562538. Epub 2014 May 27. Blood. 2014. PMID: 24868077 Free PMC article. Review.
Paraneoplastic thrombocytosis is associated with many solid tumors and often correlates with reduced survival. Recent studies suggest that a pathogenic feed back loop may be operative between platelets and tumor cells, with reciprocal interactions between tumor growth/meta …
Paraneoplastic thrombocytosis is associated with many solid tumors and often correlates with reduced survival. Recent studies suggest …
1,372 results